These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2651951

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of captopril on heavy proteinuria in patients with various glomerular diseases.
    Han DS, Ha SK, Choi KH, Lee HY.
    Yonsei Med J; 1992 Sep; 33(3):232-9. PubMed ID: 1292247
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Short-term treatment with captopril in hypertension due to acute glomerulonephritis.
    Parra G, Rodríguez-Iturbe B, Colina-Chourio J, García R.
    Clin Nephrol; 1988 Feb; 29(2):58-62. PubMed ID: 3282729
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
    Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL.
    Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M.
    Nephron Clin Pract; 2005 Sep; 99(3):c73-7. PubMed ID: 15665549
    [Abstract] [Full Text] [Related]

  • 34. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
    Kanno Y, Okada H, Suzuki H, Ikenaga H, Saruta T.
    Blood Press Suppl; 1994 Sep; 5():67-70. PubMed ID: 7889204
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G, Ben Maadi A, Remy P, Lang P, Lagrue G, Weil B.
    Nephrol Dial Transplant; 1995 Sep; 10(1):25-9. PubMed ID: 7724024
    [Abstract] [Full Text] [Related]

  • 37. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP, Raskovic M, Schimke E.
    Dtsch Med Wochenschr; 1994 Jun 03; 119(22):796-800. PubMed ID: 8205941
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec 03; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 40. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists.
    Picciotto G, Sargiotto A, Petrarulo M, Rabbia C, De Filippi PG, Roccatello D.
    J Nucl Med; 2003 Oct 03; 44(10):1574-81. PubMed ID: 14530469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.